Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Kausik Ray: How Physicians and Patients Perceive Risk in Lipid Modification Therapy
Apr 14, 2026, 09:26

Kausik Ray: How Physicians and Patients Perceive Risk in Lipid Modification Therapy

Kausik Ray, Professor of Public Health at Imperial College London, Past President of European Atherosclerosis Society, shared a post on LinkedIn about a recent article he and his colleagues co–authored, adding:

“Just how do physicians and patients think about risk when considering lipid modification therapies.

7 country perspective from our Interaspire.”

Title: Lipid management and cardiovascular risk assessment: Physician perspectives from seven countries across five WHORegions – insights from the INTERASPIRE study

Authors: Chathurangani Menaka Balasooriya, Catriona Jennings, Eanna Kenny, Dirk De Bacquer, Kausik Kumar Ray, John-Paul Corry, Agnieszka Adamska, Kornelia Kotseva, John W McEvoy, Chris Noone, Sandra Ganly, Juwairia Alali, Wael Al Mahmeed, Nooshin Bazargani, Junbo Ge, Rose Hui-Chin Jong, Diana Hui-Ping Foo, Yong Huo, Paula Luna Bonilla, Nancy Xinrong Ji, Piotr Jankowski, Yong Li, Amam Mbakwem, Lilian Mbau, Okechukwu Samuel Ogah, Elijah N Ogola, Adalberto Quintero-Baiz, Mahmoud Umar Sani, Miguel A Urina-Triana, Renata Wolfshaut-Wolak, Ahmad Syadi Mahmood Zuhdi, David Allan Wood, Jaimini Cegla

Read the Full Article on American Journal of Preventive Cardiology

Kausik Ray: How Physicians and Patients Perceive Risk in Lipid Modification Therapy

Stay updated with Hemostasis Today.